Analysis of peritoneal leukocyte population with different dialysis fluids

Clinical Nephrology

Volumn 72, Issue 2, 2009, Pages 137-142

  Palomar, R ^a   Lopez Hoyos M ^a   Morales, P ^a   Marin M J ^a   Alvarez L ^a   Ruiz Soto, M ^a   Rodrigo, E ^a   Fernandez Fresnedo G ^a   de Francisco, A L M ^a   Arias, M ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

Biocompatibility; Icodextrin; Low GDP solutions; Peritoneal dialysis; Toll like receptors

Indexed keywords

CD38 ANTIGEN; CD8 ANTIGEN; DIALYSIS FLUID; GLUCOSE DEGRADATION PRODUCT; ICODEXTRIN; LACTIC ACID; TOLL LIKE RECEPTOR 4;

ARTICLE; B LYMPHOCYTE; BIOCOMPATIBILITY; CELL COUNT; CELL POPULATION; CLINICAL ARTICLE; CYTOMETRY; HUMAN; LEUKOCYTE; LYMPHOCYTOPENIA; MONOCYTE; NATURAL KILLER CELL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION;

EID: 70350416631     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/cnp72137     Document Type: Article

References (29)

1. Anders HJ, Banas B, Schlondorff D. Signaling danger: toll-like receptors and their potential roles in kidney disease. J Am Soc Nephrol 2004; 15: 854-867.
2. Ando M, Shibuya A, YasudaMet al. Impairment of innate cellular response to in vitro stimuli in patients on continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 2005; 20: 2497-2503.
3. Ando M, Shibuya A, Tsuchiya K, Akiba T, Nitta K. Reduced expression of Toll-like receptor 4 contributes to impaired cytokine response of monocytes in uremic patients. Kidney Int. 2006; 70: 358-362.
4. Aroeira LS, Aguilera A, Selgas R et al. Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor. Am J Kidney Dis. 2005; 46: 938-948.
5. Bouts AHM, Out TA, Schröder CH et al. Characteristics of peripheral and peritoneal white blood cells in children with chronic renal failure, dialyzed or not. Perit Dial Int. 2000; 20: 748-756.
6. Chowdhury P, Sacks SH, Sheerin NS. Toll-like receptors TLR2 and TLR4 initiate the innate immune response of the renal tubular epithelium to bacterial products. Clin Exp Immunol. 2006; 145: 346-356.
7. Dadfar E, Lundahl J, Fernvik E et al. Leukocyte CD11b and CD62L expression in response to interstitial inflammation inCAPDpatients. Perit Dial Int. 2004; 24: 28-36.
8. El-Achkar TM, Huang X, Plotkin Z, Sandoval RM, Rhodes GJ, Dasher PC. Sepsis induces changes in the expression and distribution of Toll-like receptor 4 in the rat kidney. Am J Renal Physiol. 2006; 290: F1034-1043.
9. Girndt M, Sester M, Sester U, Kaul H, Kohler H. Molecular aspects of T- and B-cell function in uremia. Kidney Int. 2001; 59 (Suppl): S206-S211.
10. Grootendorst DC, Jager DJ, Brandenburg VM et al. Excellent agreement between C-reactive protein measurement methods in end-stage renal disease patients-no additional power for mortality prediction with high-sensitivity CRP. Nephrol Dial Transplant. 2007; 22: 3277-3284.
11. Gürsu ME, Özdemir A, Yalinbas B, Gürsu RU, Canbakan M, Güven B, Atasoyu EM, Keskin AT, Elci A, Barut Y. The effect of icodextrin and glucose containing solutions on insulin resistance in CAPD patients. Clin Nephrol 2006; 4: 263-268.
12. Ha H, Yu MR, Choi NH et al. Effects of conventional and new peritoneal dialysis solutions on human peritoneal mesothelial cell viability and proliferation. Perit Dial Int. 2000; 20 (Suppl): S10-S18.
13. Holmes CJ, Schockley TR. Strategies to reduce glucose exposure in peritoneal dialysis patients. Perit Dial Int. 2000; 20 (Suppl): S37-S41.
14. Hua J, Qiu de K, Li JQ, Li EL, Chen XY, Peng YS. Expression of Toll-like receptor 4 in rat liver during the course of carbon tetrachloride-induced liver injury. J Gastroenterol Hepatol. 2007; 22: 862-869.
15. Jaber BL, Cendoroglo M, Balakrishnan VS et al. Apoptosis of leukocytes: Basic concepts and implications in uremia. Kidney Int. 2001; 59 (Suppl): S197-S205.
16. Kuroki Y, Tsuchida K, Go I et al. Astudy of innate immunity in patients with end-stage renal disease: special reference to toll-like receptor-2 and-4 expression in peripheral blood monocytes of hemodialysis patients. Int J Mol Med. 2007; 19: 783-790.
17. Liberek T, Topley N, Jorrers A et al. Peritoneal dialysis fluid inhibition of phagocyte function: effects of osmolality and glucose concentration. J Am Soc Nephrol. 1993; 3: 1508-1515.
18. Montenegro J, Saracho R, Gallardo I et al. Use of pure bicarbonate-buffered peritoneal dialysis fluid reduces the incidence of CAPD peritonitis. Nephrol Dial Transplant. 2007; 22: 1703-1708.
19. Mortier S, Faict D, Lamiere NH, De Vreise AS. Benefits of switching from a conventional to a low-GPD bicarbonate/lactate-buffered dialysis solution in a rat model. Kideny Int. 2005; 67: 1559-1565.
20. Noble PW, Jiang D. Matrix regulation of lung injury, inflammation, and repair: the role of innate immunity. Proc Am Thorac Soc. 2006; 3: 401-404.
21. Parikova A, Zweers MM, Struijk DG and Krediet RT. Peritoneal effluent markers of inflammation in patients treated with icodextrin-based and glucose-based dialysis solutions. Adv Perit Dial. 2003; 19: 186-190.
22. Pecoitis-Filho R, Stenvinkel P, Heimbürger O, Lindholm B. Beyond the membrane-the role of new PD solutions in enhancing global biocompatibility. Kidney Int. 2003; 64 (Suppl): S124-S132.
23. Sansonetti PJ. The innate signaling of dangers and the dangers of innate signaling. Nat Immunol. 2006; 7: 1237-1242.
24. Sardenberg C, Suassuna P, Andreoli MCC et al. Effects of uremia and dialysis modality on polymorpho-nuclear cell apoptosis and function. Nehrol Dial Transplant. 2006; 21: 160-165.
25. Schalkwijk CG, Ter Wee PM, Teerlink T. Reduced 1,2-Dicarbonyl compounds in bicarbonate/lactate-buffered peritoneal dialysis (PD) fluids and PD fluids based on glucose polymers or amino acids. Perit Dial Int. 2000; 20: 796-798.
26. Sundaram S, Cendoroglo M, Cooker LA et al. effect of two-chambered bicarbonate lactate-buffered peritoneal dialysis fluids on peripheral blood mononuclear cell and polymorphonuclear cell function in vitro. Am J Kidney Dis. 1997; 30: 680-689.
27. Wang H-H, Lin C-y, Huang T-P. Ps of CD4/cd8 T-cell ratio in dialysis effluents predict the long-term outcome of peritonitis in patients undergoing dialysis. Nephrol Dial Transplant. 2003; 18: 1181-1189.
28. Williams JD, Craig KJ, Topley N et al. Morphologic changes in the peritoneal membrane of patients with renal disease. JAmSoc Nephrol. 2002; 13: 470-479.
29. Witowski J, Wisniewska J, Korybalska K et al. Prolonged exposure to glucose degradation products impairs viability and function of human peritoneal mesothelial cells. J Am Soc Nephrol. 2001; 12: 1341-1343.